Clinical trial
Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In…
NCT00280423 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00280423 |
|---|---|
| Title | Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia |
| Official title | A 28 Day, Polysomnographic and Subjective Assessment of GW679769 for the Treatment of Primary Insomnia: A Randomized, Double-blind, Parallel-Group, Placebo-Controlled Trial. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sleep Initiation and Maintenance Disorders, Insomnia |
| Intervention type | Drug |
| Interventions | GW679769 |
| Enrollment | 342 |
| Start date | Jan 1, 2006 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Jan 23, 2006 |
| Last update posted | Apr 15, 2015 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: